About ReinnoMed

Innovating Intelligent Surgical Energy Systems

ReinnoMed is a medical technology company dedicated to advancing surgical energy systems through intelligent innovation.

Company Overview

Founded in 2021, ReinnoMed  is a high-tech enterprise specializing in intelligent surgical energy systems.
Backed by the research strength of Shanghai University of Science and Technology and the Shanghai High-end Medical Equipment Innovation Center,
ReinnoMed integrates medical insight and engineering innovation to develop cutting-edge ultrasonic and electrosurgical systems.

Our mission is to empower global surgery with precision, safety, and efficiency, redefining the standards of intelligent surgical energy.

R&D Strength

ReinnoMed’s R&D team unites experts from biomedical engineering, clinical surgery, and industrial design — building an innovation engine that drives continuous technological evolution.
0 +

Cross-disciplinary Experts

from Biomedical Engineering & Surgery

0 +

Core Patents

in Ultrasonic and Energy Control Systems

0

Integrated R&D and Manufacturing Base

Donec pede justo, fringilla vitae, eleifend acer sem

Precision Laboratory

for vibration mechanics & energy calibration testing

Every product we design embodies rigorous research, intelligent energy control, and clinical precision.

Core Technology Highlights

ReinnoMed’s intelligent energy technology combines ultrasonic vibration, adaptive output algorithms, and real-time feedback control to achieve precise cutting and coagulation with minimal tissue damage.

Intelligent Energy Feedback

Real-time monitoring of power and impedance for optimal stability.

Adaptive Output Control

Automatically adjusts energy delivery based on tissue type.

Ultra-Low Thermal Diffusion

Minimizes collateral damage to surrounding tissue.

High Anti-Adhesion Design

Ensures clear vision and smooth surgical workflow.

Our Journey of Innovation

Key Milestones in Our Company Development

Every milestone represents ReinnoMed’s continuous pursuit of surgical innovation and medical precision.

2021 - ReinnoMed founded; RSG-100 project launched.

ReinnoMed officially established and began developing its first-generation ultrasonic surgical energy platform.

2022 - Core R&D completed.

Achieved breakthroughs in intelligent energy control algorithms and ultrasonic vibration technology.

2023 -Standardized R&D and manufacturing base established; tumor radiofrequency ablation project launched.

ReinnoMed built a full-scale production facility and established its dedicated manufacturing company, achieving stable mass production capability. At the same time, the RFA (Radiofrequency Ablation) system project was launched, extending ReinnoMed’s expertise into precision tumor treatment.

2024 - Obtained China Class III Medical Device Registration Certificate.

RSG-100 officially entered the regulated medical device market in China, marking a major milestone in clinical application readiness.

2025 - ISO 13485 Quality Management Certification achieved.

ReinnoMed enters the domestic and international market stage, expanding partnerships and preparing for overseas registration and distribution.

Our Core Values

ReinnoMed’s philosophy is rooted in precision engineering, medical insight, and continuous innovation. Every decision we make reflects our responsibility to doctors, patients, and the future of surgery.

Innovation

We continuously explore new frontiers in surgical energy systems — transforming clinical challenges into intelligent solutions.

Precision

Every ReinnoMed system is designed for surgical accuracy, delivering consistent and controlled performance in every procedure.

Safety

We uphold the highest safety standards, ensuring stable energy output and reliable clinical protection for both doctors and patients.

Efficiency

Intelligent energy management simplifies workflows, shortens surgical time, and improves patient recovery outcomes.

ReinnoMed believes that innovation and precision are not just technologies — they are our commitment to life and care.